Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miki Nakajima

Showing results (61-70 of 288) with videos related to

Pageof 29
Sort By:
Analytical Biochemistry|February 16, 2002
High-performance liquid chromatographic assay for N-glucuronidation of nicotine and cotinine in human liver microsomesMiki Nakajima, Jun-Tack Kwon, Eriko Tanaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2002
Characterization of nicotine and cotinine N-glucuronidations in human liver microsomesMiki Nakajima, Eriko Tanaka, Jun-Tack Kwon, et al.
Drug Metabolism and Pharmacokinetics|May 15, 2007
Morphine glucuronosyltransferase activity in human liver microsomes is inhibited by a variety of drugs that are co-administered with morphineYusuke Hara, Miki Nakajima, Ken-ichi Miyamoto, et al.
Icarus|September 18, 2020
Excitation of Tumbling in Phobos and DeimosAlice C Quillen, Mckenzie Lane, Miki Nakajima, et al.
Archives of Toxicology|September 18, 2010
Stimulation of pro-inflammatory responses by mebendazole in human monocytic THP-1 cells through an ERK signaling pathwayKatsuhiko Mizuno, Yasuyuki Toyoda, Tatsuki Fukami, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 13, 2022
Methionine Sulfoxide Reductase A in Human and Mouse Tissues is Responsible for Sulindac Activation, Making a Larger Contribution than the Gut MicrobiotaKeiya Hirosawa, Tatsuki Fukami, Mai Nagaoka, et al.
Drug Metabolism and Pharmacokinetics|July 3, 2009
In silico and in vitro approaches to elucidate the thermal stability of human UDP-glucuronosyltransferase (UGT) 1A9Ryoichi Fujiwara, Miki Nakajima, Tetsunori Yamamoto, et al.
Drug Metabolism and Pharmacokinetics|January 5, 2010
Inhibitory effects of Kampo medicine on human UGT2B7 activityNao Nakagawa, Miki Katoh, Yuko Yoshioka, et al.
The Journal of Toxicological Sciences|August 4, 2020
Serum miR-206 as a biomarker for drug-induced skeletal muscle injury in ratsYu Yamaura, Masayuki Kanki, Daisuke Sasaki, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 24, 2012
Preparation of a specific monoclonal antibody against human UDP-glucuronosyltransferase (UGT) 1A9 and evaluation of UGT1A9 protein levels in human tissuesShingo Oda, Miki Nakajima, Masahiko Hatakeyama, et al.
Pageof 29

Showing results (61-70 of 288) with videos related to

Sort By:
Pageof 29
Analytical Biochemistry|February 16, 2002
High-performance liquid chromatographic assay for N-glucuronidation of nicotine and cotinine in human liver microsomesMiki Nakajima, Jun-Tack Kwon, Eriko Tanaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2002
Characterization of nicotine and cotinine N-glucuronidations in human liver microsomesMiki Nakajima, Eriko Tanaka, Jun-Tack Kwon, et al.
Drug Metabolism and Pharmacokinetics|May 15, 2007
Morphine glucuronosyltransferase activity in human liver microsomes is inhibited by a variety of drugs that are co-administered with morphineYusuke Hara, Miki Nakajima, Ken-ichi Miyamoto, et al.
Icarus|September 18, 2020
Excitation of Tumbling in Phobos and DeimosAlice C Quillen, Mckenzie Lane, Miki Nakajima, et al.
Archives of Toxicology|September 18, 2010
Stimulation of pro-inflammatory responses by mebendazole in human monocytic THP-1 cells through an ERK signaling pathwayKatsuhiko Mizuno, Yasuyuki Toyoda, Tatsuki Fukami, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 13, 2022
Methionine Sulfoxide Reductase A in Human and Mouse Tissues is Responsible for Sulindac Activation, Making a Larger Contribution than the Gut MicrobiotaKeiya Hirosawa, Tatsuki Fukami, Mai Nagaoka, et al.
Drug Metabolism and Pharmacokinetics|July 3, 2009
In silico and in vitro approaches to elucidate the thermal stability of human UDP-glucuronosyltransferase (UGT) 1A9Ryoichi Fujiwara, Miki Nakajima, Tetsunori Yamamoto, et al.
Drug Metabolism and Pharmacokinetics|January 5, 2010
Inhibitory effects of Kampo medicine on human UGT2B7 activityNao Nakagawa, Miki Katoh, Yuko Yoshioka, et al.
The Journal of Toxicological Sciences|August 4, 2020
Serum miR-206 as a biomarker for drug-induced skeletal muscle injury in ratsYu Yamaura, Masayuki Kanki, Daisuke Sasaki, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 24, 2012
Preparation of a specific monoclonal antibody against human UDP-glucuronosyltransferase (UGT) 1A9 and evaluation of UGT1A9 protein levels in human tissuesShingo Oda, Miki Nakajima, Masahiko Hatakeyama, et al.
Pageof 29